Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Cash (2019 - 2025)

Pulmonx has reported Change in Cash over the past 7 years, most recently at $1.1 million for Q3 2025.

  • Quarterly Change in Cash rose 818.54% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Sep 2025, up 141.88% year-over-year, with the annual reading at -$12.6 million for FY2024, 30.58% up from the prior year.
  • Change in Cash was $1.1 million for Q3 2025 at Pulmonx, up from $913000.0 in the prior quarter.
  • Over five years, Change in Cash peaked at $8.7 million in Q1 2023 and troughed at -$39.6 million in Q4 2021.
  • The 5-year median for Change in Cash is -$8.6 million (2023), against an average of -$8.2 million.
  • Year-over-year, Change in Cash crashed 1406.63% in 2021 and then skyrocketed 818.54% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$39.6 million in 2021, then soared by 73.06% to -$10.7 million in 2022, then decreased by 6.85% to -$11.4 million in 2023, then surged by 166.61% to $7.6 million in 2024, then plummeted by 85.71% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Cash are $1.1 million (Q3 2025), $913000.0 (Q2 2025), and $3.6 million (Q1 2025).